how proximity to the fda and nih benefits your biopharmaceutical business globally

19
How Proximity to the FDA and NIH Benefits your BioPharmaceutical Business Globally Montgomery County Department of Economic Development

Upload: abia

Post on 14-Jan-2016

26 views

Category:

Documents


1 download

DESCRIPTION

How Proximity to the FDA and NIH Benefits your BioPharmaceutical Business Globally. Montgomery County Department of Economic Development. Montgomery County, Maryland. A thriving international community of 1 million highly educated people. Boasting the best schools. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

How Proximity to the FDA and NIH Benefits your

BioPharmaceutical Business Globally

Montgomery County Department of Economic Development

Page 2: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Producing a $65 Billion GDP Ranking it 58th as a countryOne of the wealthiest U.S. counties

A thriving international community of 1 million highly educated people.Boasting the best schools.

Montgomery County, Maryland

The Innovation hub of Washington, D.C.

                  

475 direct flights/week to 34 international destinations

Page 3: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Baltimore’s deepwater port

Rail: AmTrak corridor

Air: BWI, Washington-Dulles & Reagan International

UNPARALLED

BUSINESS ACCESS:100 mi.

200 mi.

400 mi.

300 mi.

500 mi.

600 mi.

Same day or overnight road access to 1/3 of

U.S. industry, markets, and population

Same day or overnight road access to 1/3 of

U.S. industry, markets, and population

Just two hour access to 80% of the U.S. pharmaceutical industry and more than

1,000 biotechnology companies

Just two hour access to 80% of the U.S. pharmaceutical industry and more than

1,000 biotechnology companies

Road: Multi interstate 95

Page 4: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Strategic Access To

• The power, Resources, Research and Regulations of the U.S. Federal Government, the single largest customer in the world

• 60 percent of the U.S. market in 2 hour flight through 3 major airports providing non-stop flights to 29 countries

• A cluster of the best scientific and business minds

Page 5: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Global Companies created and thriving in Montgomery County, MD

• Marriott Corporation

• Lockheed Martin

• Hughes Network Systems

• Discovery Communications

• Astra Zeneca/MedImmune

• Human Genome Sciences

Page 6: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Elite Workforce

• Total workforce of over 500,000• Advanced technology workforce >100,000• Most educated workforce in U.S.

– 40% hold advanced degrees– 70% with at least 4-year college

degrees– Highest proportion of Ph.D’s in the U.S.

• Diverse workforce from 160 countries

Page 7: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Connecting the 300 R&D CentersConnecting the 300 R&D Centers

Just two hour access to 80% of the U.S. pharmaceutical industry and more than

1,000 biotechnology companies

Just two hour access to 80% of the U.S. pharmaceutical industry and more than

1,000 biotechnology companies

Maryland BioScience Region

Private Sector Company Concentrations

JHU

US

AMRIID

USUHS

WRAIR

JHU

FDA

USDA

DOD

FDA

GTU

GWU

NIST

AFIP

UMBIUMB

C

NASA

DOE

BARC

NOAANIH

CMS

Page 8: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Regional Federal Assets

• USDA U.S. Department of Agriculture • FDA Food and Drug Administration • NIH National Institutes of Health including NCCAM National Center for Complementary and Alternative Medicine• CMS Center for Medicaid and Medicare • NIST National Institute of Standards and Technology• USAMRIID/Ft. Detrick U.S. Army Medical Research Institute for Infectious

Diseases • WRAIR Walter Reed Army Institute of Research• NMRC Naval Medical Research Center • BARC USDA Beltsville Agricultural Research Center• EPA Environmental Protection Agency • NOAA National Oceanographic and Atmospheric Administration

Page 9: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

• The Johns Hopkins University at Shady Grove/ and in Baltimore receives $1.5 Billion in federal research grant• The Howard Hughes Medical Institute• The University of Maryland and the University System of Maryland at Shady Grove ($800 Million)• The University of Maryland Biotechnology Institute with five separate institutes• Montgomery College• Georgetown University• George Washington University

Academic & Research Assets in addition to the Federal Assets

Page 10: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Where Science Translates into Success

+ $18 billion of

acquisitions in 2007

+ $18 billion of

acquisitions in 2007

Page 11: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

The Maryland Drug Discovery Network is a consortium of Maryland resources acting to facilitate collaborations between public and private sector resources available within the State and University of Maryland to encourage drug discovery and development, including basic research, manufacturing, education and training, pre-clinical and clinical support, and facilities.

Pre-Clinical

Multiple sites: CTSA (proposed)UM: Nanocenter

UM: Maryland Pathogen ResearchInstitute (MPRI)

UM: Fischell Dept of BioengineeringUMB: School of Pharmacy

UMB: BioMedical Core FacilitiesUMBC: College of Natural and

Mathematical SciencesUMBI: Medical Biotechnology Center

Clinical

UMB: CCTUMBC: College o f Natural and

Mathematical Sciences

Regulatory

UMBC: Degree ProgramsUMB: Center on Drugs and

Public PolicyUMB: Intellectual Property Legal

Resource Center

Manufacturing

UM: BREP and Bioprocess Scale-Up Facility

UMBI: cGMP facilityUMBC: Dept Chemical & Biochemical Eng

UMBI: Transgenic Plant Facility

Facilities

UMB: UMBBioparkUMBC: bwtech@UMBC Research Park

UM: M SquareUMBC: bwtech@UMBC Incubator

UM: TAPUM: Venture AcceleratorUMB: UMB Accelerator

Workforce Training &Education

UM: BREPUMBC: ACTiVATE

UMBC: MPS, Certificates and in-house training, BiotechUMBC: Continuing and Professional Studies

UMBC: Training CentersUMBI: Workforce Training & Outreach Center

Contacts: UMB: Jim Hughes [email protected] UM: Paul Allenza [email protected] UMBC: Antonio Moreira [email protected] UMBI: Ted Roumel [email protected]

The MarylandDrug Discovery

Network

Pre-Clinical

Clinical Regulatory

Manufacturing

Facilities Workforce Training &Education

Pre-Clinical

Clinical Regulatory

Manufacturing

Facilities Workforce Training &Education

Page 12: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Bioinformatics

Biotherapeutics& Diagnostics

Biomanufacturing& Bioprocessing

Agricultural & Industrial/Environmental

Biotechnology

Genomics Proteomics Biodefense

Industry & Research Strength

Page 13: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Maryland and Montgomery County Support Companies in:

• Recruitment and training• Networking and introductions to partners• Connection to public and private funding sources i.e. the Biotech Investment Tax credit• Facilitation of transition to new home• Innovative State and local incentive programs• Facilities

– Incubator system with 85% success rate– Science and Technology Parks

Page 14: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Montgomery County Incubator Network

Page 15: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Why Partner with us?To enhance the value of your company globally

• Access to expertise in:– Commercialization

– Regulatory affairs for drug approval and alternative medicines

– Intellectual Property, transparency, corporate governance

– U.S. public markets – increased stock value

• Maryland is the Passport to innovative companies for market entry

• A local government with 30 years of biotech experience

Page 16: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

New Projects Translate our Vision

• Montgomery County built first industrial park exclusively dedicated to the life sciences in the 1980’

• Now a partner with the Johns Hopkins University to build a world class R&D center with 500 to 1 million square feet of laboratory and office space and 10,000 housing units: a translational city

• Creating a new R&D Park next to newly consolidated headquarters of FDA

• 5 incubator facilities comprise a network

Page 17: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Work Hard, Play Hard in Your Home away from Home

• Large internationally diverse population – 1/3 foreign born coming from 160 nations

• Theater, Music, Free Museums including the Smithsonian Institution

• Restaurants of many ethnicities

• Outdoors: kayaking, soccer, polo, hiking, biking, baseball, swimming

Page 18: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

On the Green

AT&T TIGER WOODS FOUNDATION GOLF TOURNAMENT

Page 19: How Proximity to the  FDA and NIH Benefits your BioPharmaceutical Business Globally

Montgomery County Department of Economic Development Janis Pitts, Sr. Business Development Specialist

[email protected]